Minimal deviation hepatoma (Hepa) cells, from the mouse hepatoma B7756, synthesize and secrete haemopexin and express both the haemopexin receptor and the membrane haem-binding protein (MHBP) associated with the receptor, making this cell line the first available for detailed study of both haemopexin metabolism and hepatic transport. The 17.5 kDa MHBP was detected in Triton X-100 extracts of Hepa cells by immunoblotting with goat anti-rabbit MHBP. Scatchard-type analysis of haem-1251-haemopexin binding at 4°C revealed 35000 receptors per cell of high affinity (Kd 17 nM). Haemopexin-mediated haem transport at 37°C is saturable, having an apparent Km of 160 nm and a Vm'ax of 7.5 pmol of haem/106 cells per h during exponential growth. Haem-transport capacity is highest in the period just before the cells enter their exponential phase of growth and slowest in stationary phase. Interestingly, haem-haemopexin serves as effectively as iron-transferrin as the sole source of iron for cell growth by Hepa cells. Furthermore, depriving Hepa cells of iron by treatment with desferrioxamine (DF) increases the number of cell-surface haemopexin receptors to 65000 per cell and consequently increases haemopexin-mediated haem transport. The effects of DF do not appear to require protein synthesis since they are not prevented by cycloheximide. Treatment of Hepa cells with hydroxyurea, an inhibitor of the iron-requiring enzyme ribonucleotide reductase that is obligatory for DNA synthesis, enhanced haemopexin-mediated haem transport. Thus, these studies provide the first evidence for regulation of haem transport by the iron status of cells and suggest a linkage between haemopexin, iron homeostasis and cell growth.
INTRODUCTION
Haemopexin and haptoglobin are glycoproteins which act to transport haem and haemoglobin (Kino et al., 1982) , respectively, from the circulation to the liver for degradation of haem and conservation of its iron. Since evidence is accruing that haemopexin and haptoglobin form important links between haem and iron metabolism, the receptor-mediated transport of haem by haemopexin, of haemoglobin by haptoglobin and of iron by transferrin can be considered to be functionally related systems which act together to maintain iron homeostasis by the liver (Fig. 1) . The hepatic reclamation of haem by haemopexin plays a significant role in three areas, namely, in aiding 'nutritional immunity' (Kochan, 1973) , in conserving iron for re-utilization (shown here) or storage on ferritin (Davies et al., 1979) , and in preventing toxic haem effects (Braun et al., 1970; Lips et al., 1978; Liu et al., 1985; Gutteridge & Smith, 1988) . Moreover, since haemopexin (Carmel & Gross, 1977; Merriman et al., 1978; Baumann et al., 1984 Baumann et al., , 1987 and haptoglobin (Owen et al., 1964) are acute-phase plasma proteins in many mammalian species, knowledge of the regulation of their synthesis by the liver is required for understanding this inflammatory response. In addition, although transferrin is not generally considered to be an acute phase protein (Putnam, 1984) , transferrin metabolism is altered in response to infection.
Haemopexin is synthesized by the liver (Thorbecke et al., 1973) , and haem transport with degradation of haem (Davies et al., 1979 ) is a function of liver cells . The haemopexin receptor has been shown to be located in the liver of rat Tran-Quang et al., 1983) , rabbit (Smith & Morgan, 1984) and pig (Majuri & Grasbeck, 1986) . Furthermore, several recent reports provide evidence for haemopexin receptors in non-hepatic tissues, including K562 erythroleukaemic (Taketani et al., 1986) , HL-60 (Taketani et al. 1987a ) cells and in placenta (Taketani et al., 1987b) . However, a cell line of physiological relevance for characterizing both haemopexin metabolism and haemopexin-mediated haem transport has been lacking. Hepa cells were chosen for examination here because these cells secrete serum proteins (Ledford & Davis, 1983) and provide a stable, well-defined experimental system for examining the kinetics and regulation of albumin synthesis (Ledford & Davis, 1983, Ledford & This diagram depicts the basic features of the interactions of haem-haemopexin, haemoglobin-haptoglobin and iron-transferrin with the liver parenchymal cell. Morphological evidence for endocytosis of haemopexin has recently been obtained employing colloidal gold-labelled haem-haemopexin (Hunt et al., 1988; Smith, 1988) . It is not known whether haem from haemopexin and haem released from catabolism of haemoglobin-haptoglobin in lysosomes (Higa et al., 1981) join a common pool, or whether there is an equivalent to MHBP in the haptoglobin system, shown here as HBP. Many details are of necessity omitted from this simplified picture, for example, the subcellular organelles which operate in certain of the steps. MIBP denotes the membrane iron-binding protein of Glass et al. (1980) . Jacobs, 1985) . Furthermore, because they are a highly differentiated mouse hepatoma cell line (originally derived from the hepatoma BW 7756, Bernhard et al., 1973) , it seemed likely that they would express the hepatic haemopexin receptor. Mouse Hepa cells are shown here to provide an informative model system for study of the haemopexintransport system and for exploration of the relationships between hepatic haem transport, iron metabolism and cell growth.
MATERIALS AND METHODS
Haemopexin was isolated' from rabbit serum and its purity (greater than 95 %) checked as previously described Hrkal & MullerEberhard, 1971 Mesohaem (iron-mesoporphyrin IX) from Porphyrin Products (Logan, UT, U.S.A.) was used in place of haem (iron-protoporphyrin IX) in this work since mesohaem is more stable than haem, and mesohaem-haemopexin complexes are chemically and biologically equivalent to haem-haemopexin . Mesoporphyrin was also obtained from Porphyrin Products and was labelled with 55Fe (New England Nuclear, Boston, MA, U.S.A.) by refluxing in dimethylformamide and freed of unincorporated iron and metal-free porphyrin by washing with acid (Adler et al., 1970) .
Complexes of haemopexin with mesohaem were prepared by mixing one equivalent of tetrapyrrole with one equivalent of protein. Unbound tetrapyrrole was removed by passage over DEAE-cellulose (DE-52; Whatman, Clifton, NJ, U.S.A.; or by exhaustive dialysis. Concentrations were determined spectrophotometrically using absorption coefficients (M-l cm-') of 1.1 x 105 at 280nm for 1988 apo-haemopexin (Seery et al., 1972) , of 1.3 x 105 at 405 nm for mesohaem-haemopexin (Morgan & Smith, 1984) and of 1.7 x 105 at 394 nm for mesohaem in dimethyl sulphoxide (Brown & Lantzke, 1969) . Absorbance measurements were obtained with a Cary 219 spectrophotometer.
The membrane haem-binding protein (MHBP, formerly termed HBC), of the haemopexin-transport system was isolated and partially purified by ionexchange chromatography on DEAE-cellulose using published procedures . Purified MHBP, for use as antigen, was obtained by elution of gel slices after electrophoresis on non-denaturing acrylamide gels and detection of the protein by staining with Coomassie Blue G. Rabbit MHBP used elsewhere in this work, after isolation by DE 52 chromatography, had a specific activity of -2-6 A4,2/mg of protein and was approximately 60 % pure as judged by SDS/polyacrylamide-gel electrophoresis (PAGE) and silver staining. The isolation and characterization of MHBP will be described elsewhere.
Polyclonal antisera to rat haemopexin and to MHBP were raised in goats after intramuscular injection of antigen emulsified in complete Freund's adjuvant (150 ,ugofprotein), followed bya'boost 'injection (75 ,ugof protein) in incomplete Freund's adjuvant 6 weeks later. Antibodies were generally present in high titre within 7 days of the second injection. Ouchterlony plates were set up (Ouchterlony, 1951) (Laemmli, 1970) , blotting was carried out at 100 V for 2 h on to nitrocellulose (0.2 micron, BioRad) at 4 'C. Goat antisera raised in this laboratory were used at 1: 500 dilution in 5 % (w/v) Carnation non-fat skim milk powder in PBS for 16 h at 4 'C followed by incubation for 1 h at 25 'C with a 1:2500 dilution of rabbit antigoat IgG (H +.L chains) (affinity-purified, Cappel) covalently coupled to alkaline phosphatase and developed (Johnston & Zabriskie, 1986) . Triton X-100 extracts of Hepa cells used in immunoblotting experiments were made by incubating -1 x 107 washed cells with Hepes/ NaOH buffer pH 7.7, containing 0.5 % Triton X-100 and 2 mM-CaCI2, at 4 'C for 30 min followed by centrifugation at 100000 g for 1 h. These cells were routinely cultured as described below. following published procedures . Immunoprecipitation was carried out on samples of medium after extensive dialysis in the presence of proteinase inhibitors [0.2 mM-phenylmethanesulphonyl fluoride (PMSF) and 2000 k.i.u. of aprotinin/ml] to remove unincorporated radiolabel. Samples (-107-108 c.p.m.) were diluted 1:1 with 2 x buffer D (100 mM-Tris, pH 7.4, containing 2 % Triton X-100, 600 mM-NaCl, 0.2% bovine serum albumin (BSA), 0.2 mM-PMSF, 20,tg of leupeptin/ml and 40 k.i.u. of aprotinin/ml) before addition of 1.0 mg of goat anti-rat haemopexin IgG, followed by incubation for 60 min at 4 'C. Protein A-Sepharose (200 ,ul of 50 % suspension) was then added and, after further incubation at 4 'C for 90 min, the sample was centrifuged at 2000 g for 2 min. The pelleted immune complex-Protein A-Sepharose was washed extensively in 1 x buffer D (without BSA) and solubilized for analysis by SDS/PAGE on a 4.5-20% (w/v) acrylamide gradient gel.
Cell culture
Minimal deviation hepatoma cells from mouse solid tumour line BW 7756 (Hepa) cells were grown in Dulbecco's modified Eagle medium (DMEM; K.C. Biological, Kansas City, MO, U.S.A.) supplemented with 0.3500 glucose, 25 mM-gentamicin and 2 % (v/v) foetal bovine serum (FBS) (K.C. Biological) in a humidified atmosphere of 5 % C02/95 % air. Routine subculturing (1:10) was carried out every 4-5 days and cells were fed every 2-3 days. Methionine-deficient DMEM was obtained from Irvine Scientific, Irvine, CA, U.S.A. Gentamicin was included in the growth but not the experimental media.
For metabolic labelling of haemopexin the growth medium was removed, the cells were washed, treated with experimental methionine-deficient DMEM for 1 h at 37°C, and then incubated for up to 4 h in fresh experimental medium containing 35S-TRAN (50 ,Ci/ ml; specific radioactivity 993 Ci/mmol from ICN). For binding and uptake studies the cells were maintained in the exponential phase of growth. Binding of '25I-labelled protein was measured by adding 1 ml aliquots of Hepes-buffered DMEM, pH 7.2, containing the protein to (1-2) x 106 cells in one well of a six-well tissueculture dish. At the indicated time, the medium was aspirated from the well and the cells washed with 3 x 2 ml of cold 10 mM-sodium phosphate buffer, pH 7.4, containing 0.15 M-NaCl (PBS). Then NaOH (O.1 M, 2 ml) was added to dissolve the cells followed by 0.23 ml of 50 % acetic acid to neutralize. The solution (2 ml) was removed and 1251 counted in a Beckman 7500 gamma spectrometer. Uptake of 55Fe-labelled mesohaem was measured in a similar manner except that 2 ml aliquots were mixed with 13 ml of liquid-scintillation fluid (Betablend, Westchem Scientific, San Diego, CA, U.S.A.) and cell-associated 55Fe measured in a Beckman 9800 scintillation counter. In each experiment three wells were used for each determination. In these binding and haem uptake assays the standard deviation generally ranged from 3 to 10 % of the mean. Each experiment was repeated at least twice. Specific binding or specific uptake is defined as the difference in binding or uptake in the presence and absence of excess unlabelled mesohaemhaemopexin (generally 100-fold excess) added to the cells before the labelled complex. Additional details are given in the legends to the Figures and Tables. Specific binding of mesohaem-125I-haemopexin (50 nM) to the Hepa cells, at pH 7.2, was greater than 80 % of the total bound radiolabelled complex as demonstrated by competitive inhibition with 5/gM unlabelled complex. Cell counts were made on at least two wells before each experiment by releasing the cells with trypsin and counting the cells in a haemocytometer after dilution in Trypan Blue. Protein was determined on aliquots of the neutralized cell extracts using the Pierce BCA protein assay system with BSA as a standard.
For the series of cell-growth experiments employing haem-haemopexin as the sole source of iron, cells in stationary phase were detached by trypsin treatment, diluted and plated out at 0.5 x 106 cells per well in sixwell plates. After allowing cells to attach during a further 6 h incubation, the medium was then changed to either control or experimental medium and cell counts were taken 24, 48 and 72 h later. The experimental medium either consisted of DMEM containing 0.1 mg of iron/l (GIBCO) and supplemented with concentrations of serum greater than 2% or Eagle's minimal essential medium (EMEM) (GIBCO, which has no added inorganic iron salts) containing serum or supplements (see below and in the Western immunoblotting using either anti-human haemopexin or anti-rabbit haemopexin polyclonal antisera, which cross-react with bovine haemopexin (a generous gift from Dr. D. R. Babin, Creighton University, Omaha, NE, U.S.A.). Because of this contamination and because preliminary experiments established that linoleic acid was not an obligatory growth factor for these cells over the 3-day period examined, this compound was not employed in subsequent experiments. Protohaem-haemopexin, the naturally-occurring form of haem, was employed as the source of haem iron at a range of concentrations (0.75-5.0/sM) calculated to be equivalent to 0.04-2.5 mg of iron/l. This range of diferric transferrin and haem-haemopexin concentrations were chosen for investigation because: firstly, normal circulating levels of transferrin are about 33/tM, of which 30 % is saturated with iron (equivalent to -1 mg of iron/l); secondly, serum iron levels are 1-1.5 mg of iron/ 1; and thirdly, concentrations of diferric transferrin efficacious for cell growth in vitro range from 0.5 to 100 mg of transferrin/l of medium, depending upon cell type (Barnes & Sato, 1980a,b (Fig. 3a) . The haemopexin at 4 h represented 3.5 % of the total secreted radiolabelled acid-precipitable protein. In addition, the 35S-labelled protein precipitated by the immune sera from the medium was found to migrate similarly to purified rat haemopexin on PAGE (Fig. 3b) . These results established that the 35S-labelled protein isolated by the anti-rat haemopexin is mouse haemopexin secreted by these Hepa cells.
Specific binding of mesohaem-'251-haemopexin (50 nm radiolabelled complex in the presence and absence of 5/ M unlabelled complex, 15 min at 37°C, at the pH maximum of 7.2) during exponential growth constituted 86 % of total binding and was 0.6 pmol/mg of protein or 0.095 pmol/10i cells. Consistent with earlier studies (Smith & Morgan, 1981) (Fig. 5) . Because the mouse protein migrated with a slightly higher apparent Mr than rabbit MHBP, the mixing experiment in Fig. 5 , track 2 was carried out. Since only one band of enhanced intensity is seen, the large amount of other proteins present in the cell extract in track 3 appears to have retarded the migration of the mouse MHBP. Since the antisera was raised against MHBP isolated from rabbit liver membranes, these results also demonstrate that rabbit and mouse MHBP contain conserved epitopes. Haemopexin-mediated haem transport in mouse Hepa cells was demonstrated using 55Fe-mesohaem-haemopexin complexes. When these cells were in their exponential phase of growth, haem uptake at 37°C was linear for up to 4 h (see below) and saturable (Fig. 6) . Haem uptake occurred with an apparent Km of 160 nm and with a Vmax. of 7.5 pmol of haem/106 cells per h (equivalent to 75000 molecules of haem/cell per min) during exponential growth (Fig. 6) .
Relationship between haem transport and cell growth
The results presented above demonstrated that Hepa cells are a good model system for studying haemopexin metabolism and haemopexin-mediated haem transport. The first questions addressed with this system concerned the relationship between haem transport and growth. Interestingly, haem transport varies with the growth phase of the Hepa cells, being highest at 5-8 h after seeding (results not shown), just before cells enter their exponential growth phase (Fig. 7) . Under these conditions the cells have a doubling time of 11 h.
Vol. 256 Evidence for a role for haemopexin in linking haem and iron metabolism We next addressed whether the haem iron released intracellularly by haem oxygenase from haem transported by haem-haemopexin enters the same lowmolecular-mass intracellular iron pool as does iron derived from iron transferrin. Hepa cells were cultured in defined EMEM with haem-haemopexin as the sole source of iron. The results in The data were fitted to a hyperbolic binding function using a non-linear statistical curve-fitting routine; the theoretical best fit line is shown as a solid line.
chrome P-450 isoenzymes, is an extremely small fraction of the injected haem taken up by the liver (Correia et al., 1979) . At the same time the amount of haem catabolized by the liver is extensive, and it is well established that haem oxygenase releases iron from haem. Importantly, haem taken into the hepatocyte by the haemopexin receptor is rapidly degraded with iron being detectable on ferritin within 10 min after intravenous injection of haem-haemopexin (Davies et al., 1979) . Moreover, haem oxygenase is readily induced by its substrate haem (Tenhunen et al., 1970) and by haem-haemopexin in Hepa cells (J. Alam & A. Smith, unpublished observations) . Finally, the majority of cells in culture require transferrin as an obligatory growth factor due to their requirement for iron which is transported into cells by transferrin. Lack of iron or of transferrin results in decreased cell growth and division. Treatment of several different types of transformed cells with the cell-permeable iron-chelator desferrioxamine (DF) increased their number of surface transferrin receptors (Bridges & Cudkowicz, 1984; Louache et al., 1984; Ward et al., 1984) due to an increase in receptor synthesis following increased transcription of its mRNA (Mattia et al., 1984; Rao et al., 1986) . Since haem added to the medium prevents this induction of transferrin receptor mRNA (Roualt et al., 1985) , Hepa cells were deprived of iron to determine whether the haemopexin-transport system of the cells would be similarly affected. Treatment of Hepa cells with DF increases both haemopexin-mediated haem uptake (Fig.  8) and the specific binding of haem-haemopexin complexes per cell ( Table 2) Thorstensen & Romslo, 1984) . The effects of DF are dose-dependent with higher concentrations of DF producing higher levels of haem uptake (Table 3 ). However, 17 h after DF addition cell division is significantly inhibited without obvious toxic effects, but haemopexin-mediated haem uptake remains higher in these treated cells than in controls. The increase (Ledford & Jacobs, 1985) . Links between haemopexin-mediated haem transport, cell growth and iron metabolism Since hydroxyurea is an inhibitor of ribonucleotide reductase (Atkin et al., 1973) , an iron-requiring enzyme obligatory for DNA synthesis associated with cell growth (Moore, 1969) , the effects of this agent on haemopexin-mediated haem transport were examined. At doses up to 1 UM hydroxyurea had only minimal effects on cell growth, but significantly increased haemopexin-mediated haem transport (Table 4) . When cell growth was inhibited at higher levels of hydroxyurea cell protein levels were 89 + 15 % of controls in two separate experiments and cell viability was not altered. Nevertheless, haemopexin-mediated haem transport remained twice that of control cells whether expressed per mg of protein or per 106 cells. These results reinforce the concept that haem transport and metabolism are linked to cell growth and raise the possibility that one iron pool involved in the regulation of expression of haemopexin-mediated haem transport may be ribonucleotide reductase.
In conclusion, Hepa cells express all the components of haemopexin-mediated haem transport and are a useful model for studying the mechanism of action and regulation of this system. One response of liver cells to severe iron deprivation is an attempt to salvage both iron and haem iron for survival. While it is known that a significant amount of haem delivered to the liver by haemopexin is degraded and the haem iron stored on ferritin (Davies et al., 1979) , the haem or iron released from it potentially has several different intracellular fates (Fig. 1) . Cell growth can be maintained with haemhaemopexin as the sole source of iron, which strongly supports the concept that some haem iron enters the 1988 same pool as that derived from transferrin (Fig. 1) (Muller et al., 1987) , but decrease haemopexin synthesis in a rat cell line (McCraken, 1984) 
